FDA Announces Major Steps to Implement Real-Time Clinical Trials
On Apr. 28, 2026, The U.S. Food and Drug Administration announced two major steps as part of an…
On Apr. 28, 2026, The U.S. Food and Drug Administration announced two major steps as part of an…
On Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)…
On Apr. 14, 2026, Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI…
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
On Mar. 19, 2026, the U.S. Centers for Disease Control and Prevention announced that as of February 11,…
On Mar. 11, 2026, the U.S. Food and Drug Administration (FDA) announced it is implementing the Adverse Event…
On Feb. 6, 2026, a study led by researchers at Oxford Population Health reported that statins do not…
On Jan. 31, 2026, a research team from the Institute of Science Tokyo reported they became the first…
On Jan. 15, 2026, a team of Case Western Reserve University researchers announced they have discovered a particular…
On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…
On Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help…
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
On Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….
On Dec. 16, 2025, The largest-ever study testing the effectiveness of an evidence-based approach to increasing physical activity…
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
On Dec. 5, 2025, an annual report published by the Institutes of Science and Development of the Chinese…
On Dec. 1, 2025, the U.S. Food and Drug Administration (FDA) announced the deployment of agentic AI capabilities…
On Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
On Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 19, 2025, a study by researchers from Nanyang Technological University (NTU) Singapore announced they had discovered…
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…